coeruleus Ltd

pharmaceutical company focusing on Drug Repositioning of Flumazenil for REVERSING RESIDUAL HANGOVER efects of HYPNOTIC-SEDATIVE sleep drugs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rosh Pinna, IL
  • Currency USD
  • Founded September 2009
  • Employees 5
  • Website coeruleus.com

Company Summary

coeruleus is a pharmaeutical company on drug respositioning of flumazenil for reversing the residual hangover effects of hypnotic sedative sleep drugs.the first outcome activities is the recent development of flumup sublingual spray formula incorporating a high concentration of flumazenil.the addressable market relates to the sleep disorders market estimted 2010 at $3.5 bilion with 637 m monthly treatments of benzodiazpine & zolpidem.

Team

  • Bina Zilberman Peled
    PhD

    Clinical Coordinator

  • Nir Peled
    Dr.

    founder & ceo.
    Md. Phd. fccp
    Medical Oncology
    Pulmonary Medicine Fellowship
    Pulmonary Medicine Fellowship

  • Fredy Shaviv
    Bsc. Msc

    Pharmaceutical Advisor, 30 years of experience in the Pharmaceutical Industry. Former CEO Chemagis and VP Agis Industries, Israel

  • Sara Furie
    Msc

    VP Regulatory Affairs, 30 years experience in Regulatory & IP strategy. Former TEVA Pharmaceutical Ltd.

  • Giora Pillar
    Prof. Md

    Chief Investigator, Sleep Medicine Worldwide leader; Head of the sleep lab, Karmel Inst, Israel.

  • Yaacov Baruch
    Prof. Md

    Clinical Advisor, Head, Liver Unit, Rambam Medical Center, Israel

  • Zohar Ben David
    Bsc.Msc

    COO over 25 years of experience in management and financing

  • Zohar Be David

Advisors

  • Shibolet adv. and * IP Law Firm: Cynthia Webb at Webb & Co. , Israel
    Lawyer
    Unconfirmed
    PWC
    Accountant
    Unconfirmed

Previous Investors

  • COS Israel
    Unconfirmed
    Capital Venture
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free